Related Experiment Video
Updated: Apr 15, 2026
07:01
Electrophoretic Delivery of γ-aminobutyric Acid GABA into Epileptic Focus Prevents Seizures in Mice
Published on: May 16, 2019
9.7K
Interactions between antiepileptic drugs and hormones
Sigrid Svalheim1, Line Sveberg1, Monika Mochol2
1Department of Neurology, Oslo University Hospital, Oslo, Norway.
Seizure
|March 24, 2015
Summary
Antiepileptic drugs (AEDs) can cause significant endocrine side effects, impacting fertility and quality of life. Awareness and monitoring are crucial, as some effects may be reversible upon discontinuing AED treatment.
Area of Science:
- Endocrinology
- Pharmacology
- Neurology
Background:
- Antiepileptic drugs (AEDs) are essential for managing epilepsy but are associated with endocrine-related adverse effects.
- These side effects can impact critical aspects of well-being, including reproductive health, sexual function, thyroid function, and bone metabolism.
Purpose of the Study:
- To review the endocrine side effects of various AEDs.
- To highlight the impact of AEDs on sex hormones, fertility, and overall quality of life.
Main Methods:
- Literature review of studies on AEDs and endocrine function.
- Analysis of hormonal alterations induced by specific AED classes, including liver enzyme-inducing AEDs (EIAEDs) and valproate (VPA).
Main Results:
- EIAEDs (e.g., phenobarbital, phenytoin, carbamazepine) and VPA can increase sex hormone-binding globulin (SHBG), potentially lowering bioactive testosterone and estradiol.
- VPA is associated with weight gain and androgenic effects in women, including menstrual irregularities and polycystic ovaries.
- Lamotrigine appears to have a lower risk of endocrine side effects; newer AEDs require further investigation.
Conclusions:
- AEDs can cause significant endocrine disturbances affecting quality of life.
- Monitoring for and managing these side effects is essential for patient well-being.
- Some endocrine side effects may be reversible after AED discontinuation.
Related Concept Videos
01:08Antiepileptic Drugs: Sodium Channel Blockers
2.5K
Antiepileptic drugs are specialized medications that prevent seizures in individuals diagnosed with epilepsy. These drugs primarily function by blocking the movement of sodium ions through channels in the neuronal membrane, inhibiting the repetitive firing of action potentials often associated with seizures.
Sodium channel blockers modulate ion channels, particularly voltage-gated sodium channels. They block only sodium ion movement.
Among the most commonly prescribed antiepileptic drugs are...
Sodium channel blockers modulate ion channels, particularly voltage-gated sodium channels. They block only sodium ion movement.
Among the most commonly prescribed antiepileptic drugs are...
2.5K
01:17Antiepileptic Drugs: Calcium Channel Blockers
1.7K
Calcium channel blockers, a class of antiepileptic drugs, regulate the flow of calcium ions within neurons.
Calcium channel blockers exert their antiepileptic effects by targeting T-type calcium channels, which are integral to transmitting nerve signals in the central nervous system. These channels allow the passage of calcium ions, which are vital for neuronal communication. By inhibiting T-type calcium channels, calcium channel blockers effectively reduce the release of neurotransmitters and...
Calcium channel blockers exert their antiepileptic effects by targeting T-type calcium channels, which are integral to transmitting nerve signals in the central nervous system. These channels allow the passage of calcium ions, which are vital for neuronal communication. By inhibiting T-type calcium channels, calcium channel blockers effectively reduce the release of neurotransmitters and...
1.7K
01:20Antiepileptic Drugs: Potassium Channel Activators
1.0K
Ezocgabine or retigabine, an antiepileptic drug of remarkable efficacy, has revolutionized the management of seizures. It is a potassium channel activator, explicitly targeting the family of Q subtype potassium channels. It enhances the transmembrane potassium currents, regulating neuronal excitability. This action stabilizes the resting membrane potential, a pivotal factor in mitigating the hyperexcitability that characterizes epilepsy.
Ezogabine has gained approval as an adjunctive treatment...
Ezogabine has gained approval as an adjunctive treatment...
1.0K
01:25Pharmacokinetics: Drug–Drug Interactions
753
Drug interactions occur when the pharmacological effect of one drug is altered by another substance, either enhancing or diminishing its activity. The drug whose activity is altered is known as the object drug, and the substance causing the alteration is called the agent drug or the precipitant. The net effects of these interactions are mostly undesirable, leading to decreased effectiveness or increased adverse effects. In rare cases, interactions can be beneficial, such as the enhanced...
753
01:30Drug toxicity: Drug–Drug Interaction
376
Drug–drug interactions can precipitate toxicity through multiple mechanisms. Absorption interactions alter how drugs enter the body, exemplified when ranitidine increases the absorption of basic drugs, while cholestyramine decreases the levels of propranolol. Protein binding interactions occur when drugs share the same binding sites on plasma proteins. Drugs like aspirin and warfarin, when bound in excess, can lead to increased free drug concentrations, enhancing the potential for...
376
01:18Antiepileptic Drugs: GABAergic Pathway Potentiators
1.8K
γ-aminobutyric acid or GABA, plays a pivotal role as an inhibitory neurotransmitter in the brain. GABA pathway potentiators, also known as GABAergic drugs, are a class of pharmaceutical agents designed to enhance the functioning of the GABAergic system. These medications primarily treat epilepsy, a neurological disorder characterized by recurrent seizures.
The key GABA pathway potentiators used in epilepsy management are as follows.
Benzodiazepines are a well-known class of drugs used for...
The key GABA pathway potentiators used in epilepsy management are as follows.
Benzodiazepines are a well-known class of drugs used for...
1.8K